Results 171 to 180 of about 13,127,120 (318)

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Global health security: how can laboratories help?

open access: yesThe Lancet Global Health, 2017
The Lancet Global Health
doaj   +1 more source

An updated definition of global health. [PDF]

open access: yesGlob Health Res Policy
Jacobsen KH   +15 more
europepmc   +1 more source

The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat

open access: yesJournal of Infection and Public Health, 2020
S. Arshad Ali   +4 more
semanticscholar   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Vector control: time for a planetary health approach

open access: yesThe Lancet Global Health, 2017
The Lancet Global Health
doaj   +1 more source

Entitled to a healthy, thriving future

open access: yesThe Lancet Global Health, 2020
The Lancet Global Health
doaj   +1 more source

Home - About - Disclaimer - Privacy